In other parts of the world, Moderna's vaccine shares the ... times higher in people who received the J&J vaccine compared to the Pfizer-BioNTech injection. The J&J vaccine is a single-dose ...

Vaccines, antibiotics, antiviral medications and anti-inflammatory drugs are all associated with a reduced risk of dementia, researchers reported in a study published Tuesday in the journal ...

Overall, women with MS have a 26% increased risk of mental illness during pregnancy and a 33% increased risk after giving birth, compared to women without the degenerative nerve disease.

Nipah is one of the pathogens that Moderna has identified as the targets ... each will receive two doses of the investigational vaccine via injection in the shoulder muscle – 25 mcg, 50 mcg ...

MSD and partner Moderna have started a late-stage trial of their personalised cancer vaccine V940 as a combination ... dose of V940 via intramuscular (IM) injection or a matched placebo once ...

Six patients had received adenoviral vector-based vaccines (four received AstraZeneca and two received Janssen), and the others had mRNA-based vaccines (five had Pfizer and one had Moderna ... at the ...

Warning Bells Ring as Leading Epidemiologist Exposes Gates' 'Bioterrorism' Agenda** In a shocking disclosure, top epidemiologist Nicolas Hulscher of the McCullough Foundation ha ...

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

Share prices of Moderna (NASDAQ: MRNA) plummeted 58% in 2024, ranking among the worst performers in the S&P 500 index. The ...

Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight bird flu.

Chairman Larry Ellison highlighted the AI's potential in the development of mRNA-based cancer vaccines. Read more here.

In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect against H5 and H7 avian influenza viruses. In July, the company received $176 million from HHS toward its ...